Abiomed Inc.

This study tests whether using the Impella heart pump during a high-risk angioplasty improves symptoms, heart function, and overall health compared to standard care. It involves 1,252 adults with weak hearts and complex coronary artery disease. The goal is to see if the pump redu…

This study tests whether using the Impella 5.5 heart pump during and after heart surgery helps patients with very weak hearts. About 100 adults having high-risk heart procedures will receive the pump to support their heart function. The goal is to see if it reduces death, stroke,…

This study tests a temporary heart pump called Impella BTR in 10 adults with severe heart failure. The pump is placed inside the body to help the heart pump blood for up to 28 days. The goal is to see if it is safe and can support patients until their heart recovers or they recei…

This study tests a small heart pump called Impella ECP in 100 adults having a high-risk angioplasty (a procedure to open blocked heart arteries). The pump helps keep blood flowing during the procedure. The goal is to see if the device is safe and works as intended. Participants a…

This study looks at how well the Impella 5.5 heart pump works in people with weak hearts who need high-risk heart surgery. About 123 participants will be followed to see if the pump reduces complications like heart failure, stroke, or death. The goal is to gather more safety and …

This study tests if using a temporary heart pump (Impella CP) for 30 minutes before opening a blocked artery can reduce heart damage during a heart attack. About 527 people with a first-time anterior heart attack are taking part. The goal is to see if this approach works better t…

This study tests a temporary heart pump called Impella ECP in 856 adults undergoing high-risk angioplasty (a procedure to open blocked heart arteries). The pump helps keep blood flowing during the procedure. Researchers are checking how often serious heart or brain problems occur…

This study gathers detailed, real-time information from the Impella heart pump and standard monitors in 125 people with cardiogenic shock. The goal is to better understand how the pump and body work together, not to test a new treatment. Participants are already using the Impella…